Home » Business, Energy & Environment, Pharmaceuticals & Biotech, Technology » Metabolomics Technologies Market Size, Share, Trends, Growth, Analysis and Forecast to 2022: Brisk Insights
“Growing Biotechnology And Pharmaceutical Sectors Are Driving The Metabolomics Technologies Market”
BriskInsights.com has announced the addition of “Global Metabolomics Technologies Market Size, Share, Trends, Growth, Analysis And Forecast To 2022” Market Research Report to their Database.

According to a recently research report published by BriskInsights.com, the Global Metabolomics Technologies Market is expected to grow at the CAGR of XX% during 2015-2022 and it estimated to be $XX billion by 2022. The Global Metabolomics Technologies Market is segmented on the basis of application, technique, indication and geography. The report on Global Metabolomics Technologies Market forecast 2015-2022 provides detailed overview and predictive analysis of the market.

The Global Metabolomics Technologies Market is expected to grow exponentially due to huge investment from governments and rise in personalized medicine market reported by, Occams Business research. With the growing biotechnology and pharmaceutical market global metabolomics technologies market is to grow significantly in the next few years.

For More Information, List of Figure, Tables And TOC Visit –  http://www.briskinsights.com/report/metabolomics-technologies-market-forecast-2015-2022

Global Metabolomics Technologies Market is expected to contribute highest in North America followed by Europe. Rise in adoption of Global Metabolomics Technologies Market applications such as Biomarker discovery, Drug discovery and development, Toxicology testing, Nutrigenomics and so on are major drivers for the Global Metabolomics Technologies Market. Agilent technologies, Thermo fisher scientific, Biocrates Life Sciences AG, Bruker Corporation, Danaher Corporation, Human Metabolomics Technologies, inc, Leco Corporation, Metabolon, inc, Shimadzu Corporation, Waters corporation, Avacta group PLC, Merc & Co. inc, Avid radiopharmaceuticals Inc, Banyan biomarkers, Diagenic ASA, Exonhit therapeutics, Genenews ltd, Glycominds ltd, Great lakes neurotechnologies, Innogenetics biological, innovative neurotechnologies inc are the key market players. Mergers and acquisition, partnerships are the key winning strategy of the market.

Scope of the report

1. Global metabolomics technologies market by application 2012- 2022
1.1. Global Biomarker Discovery market 2012-2022 ( $ BILLION)
1.2. Global Drug Discovery/Drug Assessment market 2012-2022 ( $ BILLION)
1.3. Global Toxicology Testing market 2012-2022 ( $ billion)
1.4. Global Nutrigenomics Market 2012-2022 ( $ billion)
1.5. Global Others Market 2012-2022 ( $ billion)

2. Global metabolomics technologies market by technique 2012-2022 ( $ billion)
2.1. Global Separation Techniques Market 2012-2022 ( $ billion)
2.1.1. Global Gas Chromatography Market 2012-2022 ( $ billion)
2.1.2. Global Capillary Electrophoresis Market 2012-2022 ( $ billion)
2.1.3. Global High Performance Liquid Chromatography Market 2012-2022 ( $ billion)
2.1.4. Global Ultra Performance Liquid Chromatography Market 2012-2022 ( $ billion)

2.2. Global Detection Technique Market 2012-2022 ( $ billion)
2.2.1. Global Nuclear Magnetic Resonance Spectroscopy Market 2012-2022 ( $ billion)
2.2.2. Global Mass Spectrometry (MS) Market 2012-2022 ( $ billion)
2.2.3. Global Surface Based Mass Analysis Market 2012-2022 ( $ billion)
2.3. Global Ultra Performance Liquid Chromatography Market 2012-2022 ( $ billion)

3. Global metabolomics technologies market by indication 2012-2022 ( $ billion)
3.1. Global Oncology Market 2012-2022 ( $ billion)
3.2. Global Cardiology Market 2012-2022 ( $ billion)
3.3. Global Toxicology testing Market 2012-2022 ( $ billion)
3.4. Global Nutrigenomics Market 2012-2022 ( $ billion)
3.5. Global others Market 2012-2022 ( $ billion)

4. Global metabolomics technologies market regional outlook 2012-2022 ($ billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Middle East & Africa
4.5. Central & South America

5. Competitive Landscape
5.1. AGILENT TECHNOLOGIES
5.2. THERMO FISHER SCIENTIFIC
5.3. BIOCRATES LIFE SCIENCES AG
5.4. BRUKER CORPORATION
5.5. DANAHER CORPORATION
5.6. HUMAN METABOLOMICS TECHNOLOGIES, INC.
5.7. LECO CORPORATION
5.8. METABOLON, INC.
5.9. SHIMADZU CORPORATION
5.10. WATERS CORPORATION
5.11. APPLIED NEUROSOLUTIONS INC
5.12. AVACTA GROUP PLC
5.13. MERC & CO. IN
5.14. AVID RADIOPHARMACEUTICALS INC
5.15. BANYAN BIOMARKERS
5.16. DIAGENIC ASA
5.17. EXONHIT THERAPEUTICS
5.18. GENENEWS LTD
5.19. GLYCOMINDS LTD
5.20. GREAT LAKES NEUROTECHNOLOGIES

For More Information, List of Figure, Tables And TOC Visit –  http://www.briskinsights.com/report/metabolomics-technologies-market-forecast-2015-2022

About Us:

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to  aid businesses identify market opportunities optimize strategies.Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions.Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact:

Name: Jennifer Smith

Desig: Manager Sales

E-mail: sales@briskinsights.com

Ph: +448081890034 (UK)

Web: Brisk Insights

Blog: http://www.pdfdevices.com/

Media Contact
Company Name: Brisk Insights
Contact Person: Jennifer Smith, Manager – Sales
Email: sales@briskinsights.com
Phone: +448081890034 (UK)
Address:Office 1094 109 Vernon House Friar Lane
City: Nottingham
Country: United Kingdom
Website: http://www.briskinsights.com/report/metabolomics-technologies-market-forecast-2015-2022

Comments are closed.